Centrum f. int. Onko




          FOCUS 2018



                   CK CARE




Sie sind hier: Startseite Forschung Publikationen Publikationen 2017

Publikationen 2017

Allam, J. P.; Novak, N. (2017): [Immunological mechanisms of allergen-specific immunotherapy]. In: Hautarzt. 68 (4), S. 265–270.

Bauersachs, R.; Gerlach, H. E.; Heinken, A.; Hoffmann, U.; Langer, F.; Noppeney, T. et al. (2017): Rationale, design, and methodology of the observational INSIGHTS-SVT study on the current state of care and outcomes of patients with superficial vein thrombosis. In: J Vasc Surg Venous Lymphat Disord. 5 (4), 553-560.e1.

Beyer-Westendorf, J.; Schellong, S. M.; Gerlach, H.; Rabe, E.; Weitz, J. I.; Jersemann, K. et al. (2017): Evaluation of direct oral anticoagulants in superficial-vein thrombosis - Authors' reply. In: Lancet Haematol. 4 (6), e254-e255.

Beyer-Westendorf, J.; Schellong, S. M.; Gerlach, H.; Rabe, E.; Weitz, J. I.; Jersemann, K. et al. (2017): Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial. In: Lancet Haematol. 4 (3), e105-e113.

Bieber, T. (2017): Atopic Dermatitis 2.0: the Long and Tedious Road to Precision Medicine. In: Curr Dermatol Rep. 6 (2), S. 144–148.

Bieber, T. (2017): How to Define Atopic Dermatitis? In: Dermatol Clin. 35 (3), S. 275–281.

Bieber, T.; D'Erme, A. M.; Akdis, C. A.; Traidl-Hoffmann, C.; Lauener, R.; Schäppi, G.; Schmid-Grendelmeier, P. (2017): Clinical phenotypes and endophenotypes of atopic dermatitis: Where are we, and where should we go? In: J Allergy Clin Immunol. 139 (4S), S58-S64.

Bousquet, J.; Farrell, J.; Crooks, G.; Hellings, P.; Bel, E. H.; Bewick, M. et al. (2017): Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5). In: Clin Transl Allergy. 7, S. 5.

Bousquet, J.; Grattan, C.; Bieber, T.; Matricardi, P.; Simon, H. U.; Wahn, U. et al. (2017): Prediction and prevention of allergy and asthma in EAACI journals (2016). In: Clin Transl Allergy. 7, S. 46.

Braegelmann, C.; Jaschke, K.; Simon, B.; Hornung, T.; Bieber, T.; Wenzel, J. (2017): [79-Year-Old Male Patient in Reduced General Condition with a Pronounced Cough]. In: Dtsch Med Wochenschr. 142 (24), S. 1855–1857.

Cabanillas, B.; Brehler, A. C.; Novak, N. (2017): Atopic dermatitis phenotypes and the need for personalized medicine. In: Curr Opin Allergy Clin Immunol. 17 (4), S. 309–315.

Cheng, R.; Guo, Y.; Huang, L.; Hao, F.; Gao, X.; Bieber, T.; Yao, Z. (2017): Current status in diagnosis of atopic dermatitis in China. In: Allergy. 72 (9), S. 1277–1278.

Duan, Y. G.; Chen, S. J.; Haidl, G.; Allam, J. P. (2017): Detection of invariant natural killer T cells in ejaculates from infertile patients with chronic inflammation of genital tract. In: Am J Reprod Immunol. 78 (2), e12671.

Engel, C.; Brügmann, G.; Lambing, S.; Mühlenbeck, L. H.; Marx, S.; Hagen, C. et al. (2017): RIG-I Resists Hypoxia-Induced Immunosuppression and Dedifferentiation. In: Cancer Immunol Res. 5 (6), S. 455–467.

Erme, A. M. d'; Papadia, F.; Wenzel, J.; Bieber, T.; Romanelli, M.; Chiricozzi, A. (2017): Biomarkers for psoriasis skin lesions. In: G Ital Dermatol Venereol. 152 (5), S. 441–446.

Ferreira, M. A.; Vonk, J. M.; Baurecht, H.; Marenholz, I.; Tian, C.; Hoffman, J. D. et al. (2017): Shared genetic origin of asthma, hay fever and eczema elucidates allergic disease biology. In: Nat Genet. 49 (12), S. 1752–1757.

Giebeler, N.; Schönefuß, A.; Landsberg, J.; Tüting, T.; Mauch, C.; Zigrino, P. (2017): Deletion of ADAM-9 in HGF/CDK4 mice impairs melanoma development and metastasis. In: Oncogene. 36 (35), S. 5058–5067.

Glodde, N.; Bald, T.; van den Boorn-Konijnenberg, D.; Nakamura, K.; O'Donnell, J. S.; Szczepanski, S. et al. (2017): Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy. In: Immunity. 47 (4), 789-802.e9.

Goltz, D.; Gevensleben, H.; Dietrich, J.; Schroeck, F.; Vos, L. de; Droege, F. et al. (2017): PDCD1 (PD-1) promoter methylation predicts outcome in head and neck squamous cell carcinoma patients. In: Oncotarget. 8 (25), S. 41011–41020.

Goltz, D.; Gevensleben, H.; Grünen, S.; Dietrich, J.; Kristiansen, G.; Landsberg, J.; Dietrich, D. (2017): PD-L1 (CD274) promoter methylation predicts survival in patients with acute myeloid leukemia. In: Leukemia. 31 (3), S. 738–743.

Heinemann, A.; Wolf, D.; Brossart, P.; Rehkämper-Schäfer, C.; Bieber, T.; Wenzel, J. (2017): [Progressive induration of the skin with rough papules]. In: Hautarzt. 68 (3), S. 243–245.

Hellings, P. W.; Akdis, C. A.; Bachert, C.; Bousquet, J.; Pugin, B.; Adriaensen, G. et al. (2017): EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis. In: Rhinology. 55 (3), S. 202–210.

Hellings, P. W.; Fokkens, W. J.; Bachert, C.; Akdis, C. A.; Bieber, T.; Agache, I. et al. (2017): Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. In: Allergy. 72 (9), S. 1297–1305.

Hoffmann, F. R.; Jungblut, S.; Holst, S.; Kappertz, G.; Berlitz, P.; Ohmann, T. (2017): Treatment options after jellyfish sting in German coastal waters. In: Notfall und Rettungsmedizin. 20 (5), S. 403–409.

Klaeschen, A. S.; Wolf, D.; Brossart, P.; Bieber, T.; Wenzel, J. (2017): JAK inhibitor ruxolitinib inhibits the expression of cytokines characteristic of cutaneous lupus erythematosus. In: Exp Dermatol. 26 (8), S. 728–730.

Koch, S.; Stroisch, T. J.; Vorac, J.; Herrmann, N.; Leib, N.; Schnautz, S. et al. (2017): AhR mediates an anti-inflammatory feedback mechanism in human Langerhans cells involving Fc?RI and IDO. In: Allergy. 72 (11), S. 1686–1693.

Kroeger, K.; Storck, M.; Kujath, P.; Rabe, E.; Dissemond, J. (2017): [Prophylaxis of Recurrent Venous Leg Ulcer]. In: Zentralbl Chir. 142 (3), S. 306–311.

Layer, J. P.; Kronmüller, M. T.; Quast, T.; van den Boorn-Konijnenberg, D.; Effern, M.; Hinze, D. et al. (2017): Amplification of N-Myc is associated with a T-cell-poor microenvironment in metastatic neuroblastoma restraining interferon pathway activity and chemokine expression. In: Oncoimmunology. 6 (6), e1320626.

Maintz, L.; Wenzel, J.; Irnich, M.; Reinhard, H.; Bieber, T. (2017): Successful treatment of systemic juvenile xanthogranulomatosis with cytarabine and 2-chlorodeoxyadenosine: case report and review of the literature. In: Br J Dermatol. 176 (2), S. 481–487.

Megna, M.; Sidikov, A. A.; Zaslavsky, D. V.; Chuprov, I. N.; Timoshchuk, E. A.; Egorova, U. et al. (2017): The role of histological presentation in erythroderma. In: Int J Dermatol. 56 (4), S. 400–404.

Mescher, M.; Jeong, P.; Knapp, S. K.; Rübsam, M.; Saynisch, M.; Kranen, M. et al. (2017): The epidermal polarity protein Par3 is a non-cell autonomous suppressor of malignant melanoma. In: J Exp Med. 214 (2), S. 339–358.

Paller, A. S.; Kabashima, K.; Bieber, T. (2017): Therapeutic pipeline for atopic dermatitis: End of the drought? In: J Allergy Clin Immunol. 140 (3), S. 633–643.

Peng, W.; Grobe, W.; Walgenbach-Brünagel, G.; Flicker, S.; Yu, C.; Sylvester, M. et al. (2017): Distinct Expression and Function of Fc?RII in Human B Cells and Monocytes. In: J Immunol. 198 (8), S. 3033–3044.

Rabe, U.; Altengarten, J.; Benke, E.; Erdmann, A.; Erdmann, A. P.; Fiedler, G. et al. (2017): Long-term Effectiveness of a specific subcutaneous, MPL-adjuvanted Short-Term Immunotherapy over three Therapy- and three Post-Accident Investigations Years - measured on the Quality of Life. In: Allergo J. 26 (5), S. 20–27.

Ralser, D. J.; Basmanav, F. B.; Tafazzoli, A.; Wititsuwannakul, J.; Delker, S.; Danda, S. et al. (2017): Mutations in ?-secretase subunit-encoding PSENEN underlie Dowling-Degos disease associated with acne inversa. In: J Clin Invest. 127 (4), S. 1485–1490.

Reich-Schupke, S.; Protz, K.; Dissemond, J.; Rabe, E. (2017): [New Developments in Compression Treatment]. In: Dtsch Med Wochenschr. 142 (9), S. 679–686.

Reinhardt, J.; Landsberg, J.; Schmid-Burgk, J. L.; Ramis, B. B.; Bald, T.; Glodde, N. et al. (2017): MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy. In: Cancer Res. 77 (17), S. 4697–4709.

Schmitt, J.; Abraham, S.; Trautmann, F.; Stephan, V.; Fölster-Holst, R.; Homey, B. et al. (2017): Einsatz und Wirksamkeit von Systemtherapien bei Erwachsenen mit schwerer Neurodermitis: Erste Ergebnisse des deutschen Neurodermitis-Registers TREATgermany. In: J Dtsch Dermatol Ges. 15 (1), S. 49–60.

Scholtissek, B.; Ferring-Schmitt, S.; Maier, J.; Wenzel, J. (2017): Expression of the autoantigen TRIM33/TIF1? in skin and muscle of patients with dermatomyositis is upregulated, together with markers of cellular stress. In: Clin Exp Dermatol. 42 (6), S. 659–662.

Scholtissek, B.; Zahn, S.; Maier, J.; Klaeschen, S.; Braegelmann, C.; Hoelzel, M. et al. (2017): Immunostimulatory Endogenous Nucleic Acids Drive the Lesional Inflammation in Cutaneous Lupus Erythematosus. In: J Invest Dermatol. 137 (7), S. 1484–1492.

Schröck, A.; Leisse, A.; Vos, L. de; Gevensleben, H.; Dröge, F.; Franzen, A. et al. (2017): Free-Circulating Methylated DNA in Blood for Diagnosis, Staging, Prognosis, and Monitoring of Head and Neck Squamous Cell Carcinoma Patients: An Observational Prospective Cohort Study. In: Clin Chem. 63 (7), S. 1288–1296.

Silverberg, J. I.; Thyssen, J. P.; Paller, A. S.; Drucker, A. M.; Wollenberg, A.; Lee, K. H. et al. (2017): What's in a name? Atopic dermatitis or atopic eczema, but not eczema alone. In: Allergy. 72 (12), S. 2026–2030.

Simpson, E. L.; Bruin-Weller, M.; Flohr, C.; Ardern-Jones, M. R.; Barbarot, S.; Deleuran, M. et al. (2017): When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council. In: J Am Acad Dermatol. 77 (4), S. 623–633.

Wahn, U.; Matricardi, P. M.; Bieber, T.; Bousquet, J.; Grattan, C.; Simon, H. U. et al. (2017): Food allergy in EAACI journals (2016). In: Pediatr Allergy Immunol. 28 (8), S. 825–830.

Warren, R. B.; Mrowietz, U.; Kiedrowski, R. von; Niesmann, J.; Wilsmann-Theis, D.; Ghoreschi, K. et al. (2017): An intensified dosing schedule of subcutaneous methotrexate in patients with moderate to severe plaque-type psoriasis (METOP): a 52 week, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. In: Lancet. 389 (10068), S. 528–537.

Wolk, K.; Wenzel, J.; Tsaousi, A.; Witte-Händel, E.; Babel, N.; Zelenak, C. et al. (2017): Lipocalin-2 is expressed by activated granulocytes and keratinocytes in affected skin and reflects disease activity in acne inversa/hidradenitis suppurativa. In: Br J Dermatol. 177 (5), S. 1385–1393.

Young, A.; Ngiow, S. F.; Madore, J.; Reinhardt, J.; Landsberg, J.; Chitsazan, A. et al. (2017): Targeting Adenosine in BRAF-Mutant Melanoma Reduces Tumor Growth and Metastasis. In: Cancer Res. 77 (17), S. 4684–4696.